Gemini Bio-Products Breaks Ground on New Facility
* New state-of-the-art cGMP manufacturing facility to open in Q1 2020
WEST SACRAMENTO, CA, September 25th, 2019 – Gemini Bioproducts, LLC (“Gemini”), a leading supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced that it has broken ground on a new, state-of-the-art manufacturing facility in West Sacramento, CA. The company expects to relocate operations to the new facility during the first quarter of 2020.
The new facility will enable accelerated growth while accommodating a higher standard of quality among Gemini’s products to serve the cell and gene therapy market. The GMP facility, which spans approximately 25,000 square feet, is expected to quadruple production capacity and allow Gemini to meet its rapidly growing customer demand.
Gemini CEO Dale Gordon stated, “Our facility expansion plans are intended to support our growth by increasing capacity and allowing us to strengthen our quality systems. Through our added capabilities, we expect to be a center of excellence for cell and gene therapy companies and a trusted partner to top biopharmaceutical companies.”
Gemini offers a variety of products, including cell culture media, sera, cytokines, and growth factors. Service offerings include fill & finish and custom media development.
MarketOne Builders, a general contractor, and DGA, a science and technology architectural firm, are partnering with Gemini on the design and construction of the new facility. Gemini will be relocating from its current West Sacramento facility, which has been its headquarters since 2006.
About Gemini Bio-Products
Founded in 1985, Gemini is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community across academic research and the biotechnology, cell and gene therapy, and pharma industries. Service offerings include fill & finish and custom media development. Today, a national sales force and an international distribution network serves cell culture laboratories worldwide.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.
About MarketOne Builders
MarketOne Builders is a commercial construction company headquartered in Sacramento, California. In business for over 20 years, M1B has delivered on some of the most demanding projects in Northern California, ranging from life science, mission critical facilities, urban renovations, commercial office, healthcare, hospitality, industrial, retail, and multi-family. Among the more significant projects to date include the state-of-the-art B Street Theatre at the Sofia, Downtown Commons (DOCO), the Kings executive offices inside the Sawyer Hotel, Jackson Laboratories, EA Capital Games, and Penumbra.